Thus, we demonstrate that depletion of immunosuppressive TAMs and MDSCs results in decreased TNF-α, causing increased IL-33 levels in carcinoma cells that result in increased cytotoxic T cell response to combat metastatic PDA. Here, IL33 is linked to Patent ductus arteriosus.